What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?

What Do Prescribers of Bone Modifying Agents Know about Medication-Related Osteonecrosis of the Jaw? Is Current Prevention Enough?

Osteonecrosis of the jaw represents interference by external and internal factors in the natural bone remodeling system. Numerous bone remodeling agents (BMAs), such as bisphosphonates, denosumab, and tyrosine kinase inhibitors, can lead to medication-related osteonecrosis of the jaw (MRONJ). This i...

Full description

Bibliographic Details
Main Authors:	Mihai Vlad Golu, Ionela Pașcanu, Cornelia Togănel, Cecilia Petrovan, Adina Cosarcă, Despina Luciana Bereczki Temistocle, Alina Ormenișan
Format:	Article
Language:	English
Published:	MDPI AG 2022-09-01
Series:	Applied Sciences
Subjects:	osteonecrosis of the jaw medication-related osteonecrosis of the jaw bisphosphonate-related osteonecrosis of the jaw dentistry oral health multidisciplinary approach
Online Access:	https://www.mdpi.com/2076-3417/12/18/9224

Similar Items

<i>ONJ (MRONJ) Update 2021</i>—Osteonecrosis of Jaw Related to Bisphosphonates and Other Drugs—Prevention, Diagnosis, Pharmacovigilance, Treatment: A 2021 Web Event
by: Vittorio Fusco, et al.
Published: (2022-04-01)

Medication-related osteonecrosis of jaw and rheumatoid arthritis: Revisiting the concepts
by: Adity Bansal, et al.
Published: (2021-01-01)

Maxillary osteonecrosis of the jaw. A multidisciplinary approach, communication strategies, and technological tools for prophylaxis
by: Mihai Vlad Golu, et al.
Published: (2024-03-01)

Bisphosphonate-Related Osteonecrosis of the Jaws. A Severe Side Effect of Bisphosphonate Therapy
by: Zuzana Janovská
Published: (2012-01-01)

Clinical profile of individuals with bisphosphonate-related osteonecrosis of the jaw: an integrative review
by: Aloizio Premoli Maciel, et al.
Published: (2020-07-01)

Bisphosphonate-associated osteonecrosis of the jaws
by: Pankaj Agarwal, et al.
Published: (2012-01-01)

Surgical management in patients with bisphosphonate-related osteonecrosis of the jaw: four cases
by: Emre Dikicier, et al.
Published: (2014-12-01)

Epi-Mucosa Fixation and Autologous Platelet-Rich Fibrin Treatment in Medication-Related Osteonecrosis of the Jaw
by: Antonio Cortese, et al.
Published: (2021-04-01)

Topical erythropoietin as a novel preventive and therapeutic agent in bisphosphonate-related osteonecrosis of the jaw
by: Pantea Nazeman, et al.
Published: (2016-01-01)

Medication-related osteonecrosis of the jaw
by: Heliton Spindola Antunes, et al.
Published: (2018-08-01)

BISPHOSPHONATES RELATED OSTEONECROSIS OF THE JAW IN CANCER PATIENTS – EPIDEMIOLOGICAL STUDY
by: George Adrian Ciobanu, et al.
Published: (2022-08-01)

DENOSUMAB-RELATED OSTEONECROSIS OF THE JAWS: A CASE REPORT
by: Milena Petkova, et al.
Published: (2017-03-01)

A systematic review of microsurgical reconstruction of the jaws using vascularized fibula flap technique in patients with bisphosphonate-related osteonecrosis
by: Roberto Sacco, et al.
Published: (2011-08-01)

Experience with the treatment of bisphosphonate-related osteonecrosis of the jaw
by: Zuzana Janovska, et al.
Published: (2015-06-01)

Drug assumption and awareness about adverse drug reactions. The right to know. The case of the bone-modyfing agents: a systematic review
by: Rodolfo Mauceri, et al.
Published: (2024-08-01)

The Use of Imaging Methods in the Diagnosis of Bisphosphonate-related Osteonecrosis of the Jaw
by: L. Hauer, et al.
Published: (2012-03-01)

The Role of the Immune Response in the Development of Medication-Related Osteonecrosis of the Jaw
by: Weidong Zhang, et al.
Published: (2021-02-01)

Therapeutic Effect of Benidipine on Medication-Related Osteonecrosis of the Jaw
by: Ken Matsunaka, et al.
Published: (2022-08-01)

Epidemiological aspects of rheumatoid arthritis patients affected by oral bisphosphonate-related osteonecrosis of the jaws
by: Conte-Neto Nicolau, et al.
Published: (2012-03-01)

Development of Osteonecrosis of the Jaw in a Patient Receiving Oral Bisphosphonates for Osteoporosis: A Case Report
by: Sina Esmaeilzadeh, et al.
Published: (2014-08-01)

Osteonecrosis of the Jaw in Myeloma Patients Receiving Denosumab or Zoledronic Acid. Comment on Pivotal Trial by Raje et al. Published on Lancet Oncology
by: Vittorio Fusco, et al.
Published: (2018-09-01)

Review of the effect of biphosphonates on jaw osteonecrosis
by: Afshin Tahmasebi, et al.
Published: (2011-01-01)

Bisphosphonate-related osteonecrosis of the jaw: specificities
by: Siri Paulo, et al.
Published: (2014-09-01)

Bisphosphonate-related osteonecrosis of the jaws: Report of two cases with breast cancer, a dental concern and review of the literature
by: Ahmet Ercan Şekerci, et al.
Published: (2012-07-01)

Medication‐related osteonecrosis of the jaw leading to sepsis in a patient with rheumatoid arthritis: A case report and clinical implications
by: Kazuhiko Iwasaki, et al.
Published: (2023-06-01)

Bisphosphonate related osteonecrosis of jaw: A case report
by: Waquar Ahmed, et al.
Published: (2017-01-01)

Treatment with teriparatide for advanced bisphosphonate-related osteonecrosis of the jaw around dental implants: a case report
by: Yusuke Zushi, et al.
Published: (2017-03-01)

Bisphosphonates: An update to the general dentist
by: Varun Dahiya, et al.
Published: (2013-01-01)

Medication-Related Osteonecrosis of the Jaws (MRONJ): Etiological Update
by: Gianluca Tenore, et al.
Published: (2014-12-01)

Knowledge Level of Physicians Prescribing Bisphosphonates: Prevention and Treatment of Medication-Related Osteonecrosis of the Jaw
by: Tahereh Padeganeh, et al.
Published: (2024-10-01)

A Case of Autoimmune Hepatitis and Bisphosphonate-Related Osteonecrosis of the Jaw
by: Y.S. de Boer, et al.
Published: (2012-05-01)

Fatal infectious encephalitis as a complication of medication-related osteonecrosis of the jaw
by: Hye-Won Kim, et al.
Published: (2020-09-01)

Does Medication-Related Osteonecrosis of the Jaw Influence the Quality of Life of Cancer Patients?
by: Gianluca Tenore, et al.
Published: (2020-04-01)

OSTEONECROSIS OF THE JAW ASSOCIATED WITH SHORT-COURSE AND LOW-DOSE CORTICOSTEROID THERAPY
by: Lavinia Cristina Pădurariu, et al.
Published: (2023-12-01)

Characteristics of patients with osteonecrosis of the jaw with oral versus intravenous bisphosphonate treatment
by: Seung-Hun Lee, et al.
Published: (2021-07-01)

Strontium ranelate treatment in a postmenopausal woman with osteonecrosis of the jaw after long-term oral bisphosphonate administration: a case report
by: Pan WL, et al.
Published: (2017-07-01)

History and Etiology of Jawbones Osteonecrosis
by: L. Hauer
Published: (2009-12-01)

Ibrutinib-associated osteonecrosis of the jaw
by: Annu Singh, et al.
Published: (2024-03-01)

A retrospective case series on bisphosphonate related osteonecrosis of the jaw in 20 cats
by: Suzanna L. Hatunen, et al.
Published: (2024-08-01)

Microscopic Evaluation of the Effect of Oral Microbiota on the Development of Bisphosphonate-Related Osteonecrosis of the Jaws in Rats
by: Felipe M. Silveira, et al.
Published: (2017-01-01)